Sm. Castro et al., AMPICILLIN AND AMOXICILLIN DELAYED-HYPERSENSITIVITY - SIDE-CHAIN-SPECIFIC ALLERGIC REACTIONS IN A CHILD, Pediatric asthma, allergy & immunology, 10(4), 1996, pp. 197-203
Background: Maculopapular rashes are common cutaneous adverse reaction
s to ampicillin and amoxicillin. Usually they are not due to a known a
llergic mechanism. However, type I (IgE mediated) and type TV (T cell
mediated, delayed hypersensitivity) cutaneous reactions to beta-lactam
s in general, and especially to ampicillin and amoxicillin, can be sid
e-chain-specific. Case Report: A 30-month-old boy developed a generali
zed maculopapular rash which progressed to desquamation while the chil
d was being treated intravenously for 7 days with ampicillin. Results:
When the child was 40 months old, the maculopapular rash was reproduc
ed (onset, 5-8 hours) by a diagnostic oral challenge with amoxicillin
(one dose, 62.5 mg). Three days after onset of the rash, he was treate
d with methylprednisolone, and the rash resolved without desquamation.
Penicillin V (phenoxymethyl penicillin) challenge (62.5 mg orally) an
d trial (125 mg orally three times a day for 10 days) were negative. R
adioallergosorbent tests to penicilloyl G and penicilloyl V were negat
ive. Immediate (15 minutes) and delayed (48 hours) skin tests to penic
illin G, its major and minor determinants, and cefazolin were negative
before and after the challenges with amoxicillin and penicillin V. Im
mediate intradermal skin tests (0.02 mt) to ampicillin (0.25 and 2.5 m
g/mL) were negative. However, induration and erythema (7 x 8 mm and 10
x 10 mm) began 5 to 8 hours and reached a maximum at 48 hours after t
he tests were applied. Biopsies were not done. Conclusions: These obse
rvations emphasize that (1) ampicillin/amoxicillin maculopapular desqu
amative rashes in children can be due to delayed hypersensitivity mech
anisms, (2) betalactam ampicillin/amoxicillin delayed reactions can be
side-chain-specific (amino-benzyl group), (3) ampicillin should be in
cluded in skin testing protocols, (4) skin test sites should be examin
ed not only at 15 minutes but also at 48 hours after the tests are app
lied, and (5) other beta-lactam (not amino-benzyl) antibiotics may be
tolerated.